
Ascent Bio-Nano: NC-based manufacturer developing affordable mini flow cytometry instruments.
Founded in Morrisville, North Carolina, Ascent Bio-Nano Technologies is dedicated to developing affordable, miniature flow cytometry instruments. Leveraging patented technologies from Penn State University, the company aims to revolutionize the biomedical field by making advanced diagnostic tools more accessible and cost-effective. Their core mission is to enhance healthcare through innovative, compact, and user-friendly devices that can be widely deployed in various medical settings.
Notable affiliations include partnerships with Penn State University, which provided the foundational technologies for their products. The company has achieved significant milestones in miniaturizing flow cytometry instruments, making them more affordable without compromising on performance. Ascent Bio-Nano's impact lies in democratizing access to advanced diagnostic tools, potentially transforming how diseases are diagnosed and monitored globally.

BioNanovations
LeukoDx

NanoCytomics
nano-cytomics.com

Nanostream
nanostream.com

Ceres Nanosciences
ceresnano.com

Nanotools Bioscience
nanotoolsbio.com

BennuBio
bennubio.com

Nodexus
nodexus.com
Bioforce Nanosciences Holdings
bioforcenano.com

Standard BioTools
standardbio.com
vallum
vallumcorp.com

Nanoscope Technologies

NanoDx

Novel Microdevices
noveldx.com

Nanobiofab
nanobiofab.com

NanoCellect Biomedical
nanocellect.com

Nanovis
nanovisinc.com
Nano Mobile Healthcare

Autonomous Medical Devices
amdilabs.com

Cell Microsystems
Companies similar to Ascent Bio-Nano Technologies include BioNanovations, LeukoDx, NanoCytomics and Nanostream.
Ascent Bio-Nano Technologies was founded in 2012.
Ascent Bio-Nano Technologies' headquarters is located in Morrisville, NC, US.
Ascent Bio-Nano Technologies' most recent funding round was for $900k (USD) in August 2015.
As of Aug 28, 2015, Ascent Bio-Nano Technologies has disclosed funding of $1.2M (USD).
Ascent Bio-Nano Technologies has 2 employees as of Feb 4, 2024.